Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enterococcus faecalis | 4 | 2022 | 54 | 1.040 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2022 | 120 | 0.730 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2022 | 227 | 0.670 |
Why?
|
| Thyroid Carcinoma, Anaplastic | 2 | 2016 | 15 | 0.650 |
Why?
|
| Hedgehog Proteins | 2 | 2016 | 100 | 0.620 |
Why?
|
| Endovascular Procedures | 2 | 2022 | 276 | 0.610 |
Why?
|
| Colonic Neoplasms | 1 | 2022 | 573 | 0.590 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 340 | 0.470 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2016 | 200 | 0.470 |
Why?
|
| Thyroid Neoplasms | 2 | 2016 | 424 | 0.470 |
Why?
|
| Cell Movement | 1 | 2016 | 784 | 0.410 |
Why?
|
| Plasminogen | 2 | 2021 | 45 | 0.370 |
Why?
|
| Anastomotic Leak | 2 | 2021 | 103 | 0.340 |
Why?
|
| Colon | 3 | 2021 | 510 | 0.320 |
Why?
|
| Colorectal Neoplasms | 3 | 2020 | 981 | 0.280 |
Why?
|
| Urokinase-Type Plasminogen Activator | 2 | 2022 | 51 | 0.240 |
Why?
|
| Tranexamic Acid | 2 | 2021 | 37 | 0.230 |
Why?
|
| Collagenases | 1 | 2022 | 41 | 0.200 |
Why?
|
| Prosthesis Design | 2 | 2022 | 298 | 0.190 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2022 | 89 | 0.180 |
Why?
|
| Postoperative Complications | 3 | 2022 | 2284 | 0.180 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2022 | 243 | 0.170 |
Why?
|
| Collagen Type IV | 1 | 2019 | 26 | 0.170 |
Why?
|
| Fibrinolysis | 1 | 2019 | 37 | 0.170 |
Why?
|
| Diet, Western | 1 | 2019 | 38 | 0.170 |
Why?
|
| Collagen Type I | 1 | 2019 | 72 | 0.170 |
Why?
|
| Chromones | 2 | 2016 | 31 | 0.170 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2019 | 50 | 0.170 |
Why?
|
| Snail Family Transcription Factors | 2 | 2016 | 46 | 0.160 |
Why?
|
| Stents | 2 | 2022 | 405 | 0.160 |
Why?
|
| Morpholines | 2 | 2016 | 69 | 0.160 |
Why?
|
| Colectomy | 1 | 2019 | 172 | 0.150 |
Why?
|
| Surgical Wound Infection | 1 | 2019 | 201 | 0.150 |
Why?
|
| Wound Healing | 1 | 2019 | 359 | 0.140 |
Why?
|
| Veratrum Alkaloids | 1 | 2016 | 10 | 0.140 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2016 | 21 | 0.130 |
Why?
|
| Vimentin | 1 | 2016 | 46 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 97 | 0.130 |
Why?
|
| Phenotype | 1 | 2022 | 2440 | 0.130 |
Why?
|
| Mice | 4 | 2022 | 11761 | 0.130 |
Why?
|
| Cell Line, Tumor | 3 | 2016 | 2558 | 0.130 |
Why?
|
| Cadherins | 1 | 2016 | 163 | 0.120 |
Why?
|
| Hydroxybutyrates | 1 | 2014 | 27 | 0.120 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2014 | 46 | 0.120 |
Why?
|
| Enzyme Activation | 1 | 2016 | 698 | 0.120 |
Why?
|
| Aniline Compounds | 1 | 2014 | 59 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2016 | 3384 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 576 | 0.120 |
Why?
|
| Pyridines | 1 | 2016 | 315 | 0.110 |
Why?
|
| Pyrimidines | 1 | 2016 | 374 | 0.110 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 509 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 162 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2014 | 509 | 0.100 |
Why?
|
| Animals | 5 | 2022 | 27369 | 0.100 |
Why?
|
| Humans | 9 | 2022 | 89356 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 605 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2022 | 8241 | 0.080 |
Why?
|
| Collagen | 2 | 2021 | 293 | 0.080 |
Why?
|
| Anastomosis, Surgical | 2 | 2020 | 273 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 1088 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2014 | 1653 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 788 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 3218 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2366 | 0.060 |
Why?
|
| Enema | 1 | 2021 | 39 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2021 | 277 | 0.050 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2021 | 202 | 0.040 |
Why?
|
| Organic Chemicals | 1 | 2019 | 34 | 0.040 |
Why?
|
| Infliximab | 1 | 2020 | 159 | 0.040 |
Why?
|
| Antifibrinolytic Agents | 1 | 2019 | 39 | 0.040 |
Why?
|
| Proteolysis | 1 | 2019 | 110 | 0.040 |
Why?
|
| Pseudomonas Infections | 1 | 2019 | 99 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 248 | 0.040 |
Why?
|
| Virulence | 1 | 2019 | 280 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1652 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2019 | 211 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 237 | 0.040 |
Why?
|
| Intestines | 1 | 2019 | 416 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 487 | 0.030 |
Why?
|
| Bacteria | 1 | 2020 | 478 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 281 | 0.030 |
Why?
|
| Crotonates | 1 | 2014 | 12 | 0.030 |
Why?
|
| Toluidines | 1 | 2014 | 18 | 0.030 |
Why?
|
| Butadienes | 1 | 2014 | 34 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2014 | 45 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2014 | 15 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2018 | 377 | 0.030 |
Why?
|
| Isoxazoles | 1 | 2014 | 77 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2014 | 65 | 0.030 |
Why?
|
| Pyrazines | 1 | 2014 | 94 | 0.030 |
Why?
|
| Nitriles | 1 | 2014 | 160 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 838 | 0.030 |
Why?
|
| Imidazoles | 1 | 2014 | 148 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 198 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 247 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 267 | 0.030 |
Why?
|
| Risk Factors | 1 | 2022 | 5499 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1047 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 9057 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 2566 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 1549 | 0.020 |
Why?
|
| United States | 1 | 2018 | 6989 | 0.020 |
Why?
|
| Male | 1 | 2019 | 42411 | 0.010 |
Why?
|